Results 241 to 250 of about 279,274 (345)

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening. [PDF]

BMC Cancer, 2016
Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH.   +5 more
europepmc   +1 more source

Sculpting the Future of Bone: The Evolution of Absorbable Materials in Orthopedics

Advanced Materials, EarlyView.
This review summarizes the current status of polymeric, ceramic, and metallic absorbable materials in orthopedic applications, and highlights several innovative strategies designed to enhance mechanical performance, control degradation, and promote bioactivity. We also discuss the progress and translational potential of absorbable materials in treating
Zhao Wang, Zehui Lv, Xuejie Cai, Yingjie Wang, Bo Peng, Haojing Xu, Hualuo Pang, Xingdong Yang, Jiawei Xu, Yixin Bian, Bin Feng, Peng Wen, Yufeng Zheng, Xisheng Weng   +13 more
wiley   +1 more source

Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? [PDF]

J Radiat Res, 2017
Jeremic B, Casas F, Dubinsky P, Gomez-Caamano A, Cihoric N, Videtic G, Latinovic M.   +6 more
europepmc   +1 more source

Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups

Advanced Materials, EarlyView.
An acid‐responsive polymeric micelle system based of aliphatic poly(carbonate)s with benzyl ketal side chains is designed for targeted immunodrug delivery. It can disassemble in endosomal environments, enabling site‐specific immunoactivation and enhanced biodegradability.
Adrian V. Hauck, Michael Fichter, Laura J. Rosenberger, Jannis Willig, Alexander Fuchs, Felicia Schön, Paul Schneider, Carolina Medina‐Montano, Taufiq Ahmad, Jessica Erlenbusch, Pol Besenius, Leonard Kaps, Matthias Bros, Stephan Grabbe, Volker Mailänder, Jürgen Groll, Lutz Nuhn   +16 more
wiley   +1 more source

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

JAMA Oncol, 2018
Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.   +9 more
europepmc   +1 more source

Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer. [PDF]

Clin Lung Cancer, 2017
Zaki M, Dominello M, Dyson G, Gadgeel S, Wozniak A, Miller S, Paximadis P.   +6 more
europepmc   +1 more source

Optoacoustic‐Guided Magnetic Microrobot Platform for Precision Drug Delivery

Advanced Materials, EarlyView.
Optoacoustically guided FePt@ZIF‐8‐based microrobots are designed with high drug loading capacity, controllable locomotion, and deep‐tissue imaging capability. By integrating navigation, drug release, and real‐time monitoring into a single platform, they provide a versatile tool for precise intervention, opening new possibilities for treating ...
Fan Wang, Erdost Yildiz, Xosé Luís Deán‐Ben, Yan Yu, Daniil Nozdriukhin, Wenbin Kang, Shuaizhong Zhang, Jelena Zinnanti, Devin Sheehan, Ren Hao Soon, Shuxin Lyu, Daniel Razansky, Metin Sitti   +12 more
wiley   +1 more source

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer. [PDF]

Front Oncol, 2016
Dal Pra A, Locke JA, Borst G, Supiot S, Bristow RG.   +4 more
europepmc   +1 more source

Combined modality therapy for naso-oropharyngeal solitary extramedullary plasmacytoma: case report

, 2017
A. Masarykova, M. Dzongov, A. Hanicova, Ingrid Zavacka, D. Šćepanović   +4 more
openalex   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source